In the near future, the elderly and the disabled will face a double whammy: higher premiums for Part D drug insurance and higher prices at the pharmacy. This is on top of negotiated prices (and the consequent drop in new drug production) which will kick in later in the decade.
John Goodman and Linda Gorman explain why this will happen in The Hill.